Kaken Pharmaceutical Co., Ltd.
4521.T
#6436
Rank
NZ$1.56 B
Marketcap
NZ$41.41
Share price
-0.13%
Change (1 day)
N/A
Change (1 year)

Kaken Pharmaceutical Co., Ltd. (4521.T) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$42.09 Million

According to Kaken Pharmaceutical Co., Ltd.'s latest financial reports the company's total debt is NZ$42.09 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Kaken Pharmaceutical Co., Ltd. - Total debt on balance sheet (from 2008 to 2026)

Total debt by year

Year Total debt Change
2026-03-31NZ$42.17 M-6.87%
2025-03-31NZ$45.28 M6.62%
2024-03-31NZ$42.47 M-7.86%
2023-03-31NZ$46.1 M1.09%
2022-03-31NZ$45.6 M-8.39%
2021-03-31NZ$49.77 M-17.27%
2020-03-31NZ$60.17 M17.62%
2019-03-31NZ$51.15 M1.56%
2018-03-31NZ$50.37 M1.44%
2017-03-31NZ$49.65 M-0.24%
2016-03-31NZ$49.77 M-20.17%
2015-03-31NZ$62.35 M28.4%
2014-03-31NZ$48.56 M-55.36%
2013-03-31NZ$0.10 B-13.38%
2012-03-31NZ$0.12 B-7.04%
2011-03-31NZ$0.13 B3.87%
2010-03-31NZ$0.13 B-12.77%
2009-03-31NZ$0.14 B40.83%
2008-03-31NZ$0.10 B-4.95%
2007-03-31NZ$0.11 B-57.24%
2006-03-31NZ$0.26 B-22.8%
2005-03-31NZ$0.33 B